Abraham Ceesay

Companies

• Charles River LaboratoriesBoard member May 29, 2025 to now¹
• Rapport Therapeutics, Inc.Board member Jun 6, 2024 to now²
• Rapport Therapeutics, Inc.Chief executive officer Jun 6, 2024 to now²
• Pacira BioSciences, Inc.Board member Oct 11, 2023 to now³
• Cerevel Therapeutics Holdings, Inc.President May 13, 2021 to Feb 8, 2023⁴
• scPharmaceuticals (United States)Chief operating officer Nov 16, 2017 to Jan 19, 2018⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RTRapport Therapeutics, Inc. RAPP477,496 shares⁶$14.1M at $29.57Sep 24, 2026
• PBPacira BioSciences, Inc. PCRX9,039 shares⁷$328.4K at $36.33Sep 4, 2025
• CTCerevel Therapeutics Holdings, Inc.0 shares⁸Sep 8, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 23, 2026Sold 43 shares at $41.05 of Rapport Therapeutics, Inc.⁶
• Sep 23, 2026Sold 215 shares at $39.86 of Rapport Therapeutics, Inc.⁶
• Sep 23, 2026Sold 1,952 shares at $39.05 of Rapport Therapeutics, Inc.⁶
• Sep 8, 2026Sold 1,069 shares at $46.01 of Rapport Therapeutics, Inc.⁹
• Sep 8, 2026Sold 7,141 shares at $45.56 of Rapport Therapeutics, Inc.⁹
• Aug 25, 2026Sold 18,921 shares at $49.57 of Rapport Therapeutics, Inc.¹⁰
• Aug 11, 2026Sold 5,794 shares at $48.62 of Rapport Therapeutics, Inc.¹¹
• Aug 11, 2026Sold 19,500 shares at $48.04 of Rapport Therapeutics, Inc.¹¹
• Aug 11, 2026Sold 3,664 shares at $46.90 of Rapport Therapeutics, Inc.¹¹
• Aug 10, 2026Sold 8,370 shares at $46.75 of Rapport Therapeutics, Inc.¹¹
• Aug 10, 2026Sold 14,171 shares at $45.97 of Rapport Therapeutics, Inc.¹¹
• Jul 27, 2026Sold 7 shares at $42.74 of Rapport Therapeutics, Inc.¹²
• Jul 27, 2026Sold 2,203 shares at $42.11 of Rapport Therapeutics, Inc.¹²
• Jul 14, 2026Sold 2,729 shares at $40.57 of Rapport Therapeutics, Inc.¹³
• Jul 14, 2026Sold 5,481 shares at $39.72 of Rapport Therapeutics, Inc.¹³
• Jun 29, 2026Sold 876 shares at $40.34 of Rapport Therapeutics, Inc.¹⁴
• Jun 29, 2026Sold 7,344 shares at $39.77 of Rapport Therapeutics, Inc.¹⁴
• May 8, 2026Granted 1,438 shares at $177.62 of CIK 1100682¹⁵
• Feb 18, 2026Sold 2,100 shares at $29.80 of Rapport Therapeutics, Inc.¹⁶
• Feb 18, 2026Sold 2,983 shares at $29.04 of Rapport Therapeutics, Inc.¹⁶
• Feb 18, 2026Sold 2,281 shares at $29.80 of Rapport Therapeutics, Inc.¹⁶
• Feb 18, 2026Sold 3,552 shares at $29.05 of Rapport Therapeutics, Inc.¹⁶
• Jan 20, 2026Sold 5,083 shares at $26.11 of Rapport Therapeutics, Inc.¹⁷
• Jan 20, 2026Sold 5,833 shares at $26.12 of Rapport Therapeutics, Inc.¹⁷
• Dec 17, 2025Sold 515 shares at $31.04 of Rapport Therapeutics, Inc.¹⁸